AXA Framlington Health A Acc

Quick Stats

Bid Price - Offer Price -
Mid Price GBX 149.10 Day Change GBX +1.80 (1.22%)
Price Date 27 Feb 2017 Crown Rating 3
Shares Class Inc. Yield 0.44 %
Total Expense Ratio 0.00 Fund Size 551,370,400.00
Launch Date 27/02/1987 Standard Initial Charge (%) 0.00
Currency GBX ISA Eligible No
Annual Management Charge (%) 0.65 Sector IMA UK Equity Income
Min Investment (£) 1,000,000.00 Total Expense Ratio (%) 0.00
ISIN GB00BP8XZG68 Min TopUp (£) 5,000.00

Fund Objective

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies

Fund Managers

Dani Saurymper
Dani Saurymper joined AXA IM in April 2015 as Portfolio Manager for the AXA Framlington Health funds. Dani has 14 years’ experience. Prior to joining AXA IM in April 2015 as Portfolio Manager, he was a senior equity research analyst covering European Healthcare at Barclays Capital. Dani started his career at Goldman Sachs as a senior pharmaceutical analyst covering European Pharmaceuticals, before moving to Nomura as a sector specialist covering global healthcare Dani graduated from Leeds University with a BSc in Management Studies and Pharmacology and holds an MSc in International Business from the Manchester School of Management, UMIST.